≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Aspergillosis

EFO Endpoint Browser PheWeb

AB1_ASPERGILLOSIS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — B44
  • Hospital discharge: ICD-9 — 1173
  • Hospital discharge: ICD-8 — 1173
  • Cause of death: ICD-10 — B44
  • Cause of death: ICD-9 — 1173
  • Cause of death: ICD-8 — 1173

2 out of 7 registries used, show all original rules.

272

4. Check minimum number of events

None

272

5. Include endpoints

None

272

6. Filter based on genotype QC (FinnGen only)

272

Control definitions (FinnGen only)

Control exclude
AB1_MYCOSES

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1897 694 1166
Only index persons 1320 508 812
Unadjusted period prevalence (%)
Whole population 0.03 0.02 0.03
Only index persons 0.03 0.02 0.03
Median age at first event (years)
Whole population 62.18 61.22 62.71
Only index persons 62.61 60.94 63.65

-FinnGen-

Key figures

All Female Male
Number of individuals 272 100 172
Unadjusted period prevalence (%) 0.06 0.03 0.08
Median age at first event (years) 62.48 58.19 64.97

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
243
Matched controls
2431
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B44.1
ICD-10 Finland
Other pulmonary aspergillosis
+∞
126.4
110
*
J02AC03
ATC
voriconazole; systemic
1515.4
104.3
94
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
28.2
67.0
94
53
B44.0
ICD-10 Finland
Invasive pulmonary aspergillosis
+∞
66.8
61
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
18.2
61.8
103
94
J18.9
ICD-10 Finland
Pneumonia, unspecified
9.6
55.9
153
365
B44.9
ICD-10 Finland
Aspergillosis, unspecified
+∞
55.4
51
*
TGC00
NOMESCO Finland
Bronchial lavation
40.5
54.3
68
23
B44.8
ICD-10 Finland
Other forms of aspergillosis
+∞
50.8
47
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
12.3
49.0
98
126
J01MA14
ATC
moxifloxacin; systemic
12.8
47.1
91
108
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
33.5
46.6
61
24
R03BB04
ATC
tiotropium bromide; inhalant
11.3
46.0
96
132
J47
ICD-10 Finland
Bronchiectasis
80.5
41.8
46
7
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
14.4
40.4
72
69
J01MA12
ATC
levofloxacin; systemic
7.1
39.3
120
293
GD1AA
NOMESCO Finland
Thorax X-ray examination
6.6
39.2
182
760
H02AB06
ATC
prednisolone; systemic
6.5
38.5
184
787
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
6.7
35.6
111
271
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
21.7
35.1
52
30
J45.0
ICD-10 Finland
Predominantly allergic asthma
11.5
34.8
69
81
GD1AD
NOMESCO Finland
Thorax CT examination
17.1
31.6
51
37
J45.9
ICD-10 Finland
Asthma, unspecified
6.6
31.4
95
216
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
8.6
30.7
73
116
R03AK06
ATC
salmeterol and fluticasone; inhalant
6.8
30.0
86
180
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
6.1
29.0
92
219
J45.1
ICD-10 Finland
Nonallergic asthma
12.0
27.5
52
54
R03DC03
ATC
montelukast; oral
6.4
27.0
80
172
H02AB04
ATC
methylprednisolone; systemic
6.6
26.9
78
163
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
12.5
23.5
43
41
R03AK08
ATC
formoterol and beclometasone; inhalant
13.1
23.0
41
37
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
9.1
22.9
50
67
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
4.0
22.8
161
802
R04.2
ICD-10 Finland
Haemoptysis
11.2
22.8
44
47
XG410
NOMESCO Finland
Flow-volume spirometry
11.1
21.7
42
45
R03AC12
ATC
salmeterol; inhalant
11.1
21.7
42
45
127
Kela drug reimbursment
Transplant complication
24.2
21.4
30
14
A31.0
ICD-10 Finland
Pulmonary mycobacterial infection
+∞
21.1
20
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
7.8
20.7
50
78
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
17.4
20.4
32
21
L03AA02
ATC
filgrastim; parenteral
15.7
20.2
33
24
H62.2*B44.8
ICD-10 Finland
Otitis externa in aspergillosis
+∞
20.1
19
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.1
19.5
69
176
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
8.3
19.2
44
63
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.3
19.2
44
63
R03AC02
ATC
salbutamol; inhalant
3.5
19.2
158
841
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
76.1
19.0
21
*
JN4BD
NOMESCO Finland
Extensive body CT
5.4
18.8
62
146
J01FA06
ATC
roxithromycin; oral
3.4
18.4
131
618
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
8.8
18.3
40
53
R03BA05
ATC
fluticasone; inhalant
4.4
18.1
75
223
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.3
17.8
59
139
J02AC04
ATC
posaconazole; systemic
182.0
16.7
17
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.4
16.7
68
198
R03BA01
ATC
beclometasone; inhalant
4.6
16.4
63
172
R03DA04
ATC
theophylline; systemic, rectal
6.9
16.4
42
71
R03AC13
ATC
formoterol; inhalant
9.2
16.2
34
42
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.3
16.1
110
488
R50.9
ICD-10 Finland
Fever, unspecified
4.4
16.1
65
187
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
6.9
16.0
41
69
GDC00
NOMESCO Finland
Lobectomy of lung
64.5
16.0
18
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
4.9
15.8
56
141
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
6.1
15.5
44
85
49300
ICD-8 Finland
Asthma, bronchiale
20.0
15.0
22
12
J01.0
ICD-10 Finland
Acute maxillary sinusitis
3.8
14.8
73
249
J45.8
ICD-10 Finland
Mixed asthma
12.0
14.4
26
24
TPH04
NOMESCO Finland
Cathetrisation of vein
3.5
14.2
79
295
A02BC02
ATC
pantoprazole; systemic
3.1
14.2
181
1182
UDH02
NOMESCO Finland
Rhinopharyngoscopy
6.6
14.2
37
64
XW000
NOMESCO Finland
Bone marrow biopsy
7.6
14.0
33
49
H02AB07
ATC
prednisone; oral
4.1
14.0
60
180
TDM10
NOMESCO Finland
Puncture of maxillary antrum
9.7
13.9
28
32
H02AB09
ATC
hydrocortisone; systemic
16.0
13.9
22
15
R81
ICPC
Pneumonia
12.5
13.6
24
21
L04AA06
ATC
mycophenolic acid; systemic
19.7
13.6
20
11
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
147.9
13.6
14
*
WW500
NOMESCO Finland
Blood transfusion
9.4
13.2
27
32
J01FA15
ATC
telithromycin; oral
4.9
13.1
45
108
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
53.0
13.0
15
*
A07AA02
ATC
nystatin; oral
6.5
13.0
34
59
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.8
12.8
44
106
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
34.1
12.7
16
5
J01FF01
ATC
clindamycin; systemic
3.0
12.7
96
438
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
15.4
12.5
20
14
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
12.5
95
434
J05AB11
ATC
valaciclovir; oral
4.2
12.5
51
146
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.9
11.9
93
432
J45
ICD-10 Finland
Asthma
4.7
11.9
42
104
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.4
11.8
63
224
R06.0
ICD-10 Finland
Dyspnoea
3.0
11.8
82
351
Z2446
NOMESCO Finland
Social worker
5.3
11.6
36
77
J01AA02
ATC
doxycycline; systemic
3.2
11.6
205
1529
R03AK07
ATC
formoterol and budesonide; inhalant
3.4
11.6
64
234
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
9.1
11.6
24
29
J17.2*B44.0
ICD-10 Finland
Pneumonia in invasive aspergillosis
+∞
11.5
11
*
J02AC05
ATC
isavuconazole; systemic
+∞
11.5
11
*
L04AD01
ATC
ciclosporin; systemic
11.4
11.5
21
20
J01FA10
ATC
azithromycin; systemic
2.6
11.4
151
942
J02AC02
ATC
itraconazole; systemic
3.4
11.4
62
224
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
37.0
11.4
14
*
J01FA09
ATC
clarithromycin; systemic
2.8
11.4
96
464
A05AA02
ATC
ursodeoxycholic acid; oral
14.8
11.2
18
13
R01AD09
ATC
mometasone; nasal
2.6
11.1
116
633
A04AA01
ATC
ondansetron; systemic, rectal
5.2
10.8
34
74
J02AC01
ATC
fluconazole; systemic
2.7
10.7
95
470
R03BA02
ATC
budesonide; inhalant
3.2
10.7
63
240
R03AK11
ATC
formoterol and fluticasone; inhalant
10.8
10.7
20
20
R03BA08
ATC
ciclesonide; inhalant
4.8
10.7
36
85
N02AA05
ATC
oxycodone; systemic
3.4
10.6
57
202
ZXD05
NOMESCO Finland
Urgent procedure
2.6
10.5
96
483
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
114.8
10.5
11
*
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
6.2
10.5
28
50
ZX120
NOMESCO Finland
Intravenous
4.3
10.5
40
107
JN4CD
NOMESCO Finland
Very extensive body CT
6.6
10.3
26
43
WX892
NOMESCO Finland
Monitored bed care
4.6
10.3
36
88
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.7
10.2
35
84
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
10.1
69
290
J46
ICD-10 Finland
Status asthmaticus
9.4
10.0
20
23
Z01.8
ICD-10 Finland
Other specified special examinations
2.9
9.8
68
289
XF400
NOMESCO Finland
ECG with 12 standard connections
3.0
9.7
61
242
WW200
NOMESCO Finland
Immunization
8.1
9.6
21
28
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
18.5
9.5
14
8
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.6
9.5
86
423
UDM02
NOMESCO Finland
Sinoscopy
13.1
9.5
16
13
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
31.4
9.5
12
*
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
10.1
9.4
18
19
B44.7
ICD-10 Finland
Disseminated aspergillosis
+∞
9.4
9
*
J17.2*B44.1
ICD-10 Finland
Pneumonia in other aspergillosis
+∞
9.4
9
*
XG474
NOMESCO Finland
Exhalation nntrogen oxide
8.3
9.3
20
26
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
8.0
9.1
20
27
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
5.1
9.1
28
60
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
5.3
9.0
27
56
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
5.6
8.8
25
49
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
51.9
8.7
10
*
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
6.9
8.7
21
33
C03CA01
ATC
furosemide; systemic
2.5
8.7
87
449
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
7.8
8.6
19
26
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
28.7
8.6
11
*
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
93.2
8.5
9
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.7
8.5
63
276
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
11.3
8.4
15
14
R01AD08
ATC
fluticasone; nasal
2.5
8.4
76
371
Z94.2
ICD-10 Finland
Lung transplant status
+∞
8.4
8
*
J01DA01
ATC
[U] cefalexin; systemic
2.2
8.3
159
1111
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
9.4
8.2
16
18
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.8
8.0
26
59
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.5
8.0
38
123
R01AD12
ATC
fluticasone furoate; nasal
2.5
7.9
74
367
TPH07
NOMESCO Finland
Cathetrisation of artery
3.3
7.9
40
136
J01DB01
ATC
cefalexin; oral
2.5
7.9
200
1576
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.2
7.8
29
76
J01MA02
ATC
ciprofloxacin; systemic
2.2
7.8
112
683
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
46.5
7.8
9
*
R03AC03
ATC
terbutaline; inhalant
3.2
7.7
42
148
J01CA04
ATC
amoxicillin; systemic
2.4
7.7
196
1535
N03AX16
ATC
pregabalin; oral
2.5
7.6
70
344
M05BA04
ATC
alendronic acid; oral
3.8
7.5
31
89
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
13.9
7.5
12
9
D72.1
ICD-10 Finland
Eosinophilia
82.5
7.5
8
*
R03DC01
ATC
zafirlukast; oral
11.4
7.4
13
12
R03BB01
ATC
ipratropium bromide; inhalant
5.2
7.4
22
46
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.4
7.4
26
65
J96.1
ICD-10 Finland
Chronic respiratory failure
6.9
7.3
17
26
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
31.0
7.2
9
*
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
20.8
7.2
10
5
J98.1
ICD-10 Finland
Pulmonary collapse
20.8
7.2
10
5
AA1AD
NOMESCO Finland
CT of head and brain
2.4
7.2
69
344
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
4.6
7.2
24
57
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.7
7.1
30
88
R4110
NOMESCO Finland
Physiotherapy
2.3
7.1
78
414
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.6
7.0
53
234
J96.0
ICD-10 Finland
Acute respiratory failure
14.3
7.0
11
8
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
5.6
6.9
19
36
L03AA13
ATC
pegfilgrastim; parenteral
5.6
6.9
19
36
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
11.4
6.9
12
11
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
11.4
6.9
12
11
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
41.2
6.8
8
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.6
6.7
22
51
M04AA01
ATC
allopurinol; systemic
2.7
6.7
46
191
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
12.7
6.6
11
9
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.1
6.6
37
134
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.3
6.6
66
335
RS220
NOMESCO Finland
NA
10.4
6.6
12
12
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.0
6.6
17
30
SPAT1255
SPAT
Intravenous administration of medicine
4.0
6.5
25
68
A02BC01
ATC
omeprazole; systemic
2.2
6.5
76
413
6BA02
NOMESCO Finland
NA
71.7
6.5
7
*
ZX108
NOMESCO Finland
Inhalation
14.8
6.5
10
7
ZXE40
NOMESCO Finland
More than seven and less than nine hours
6.9
6.4
15
23
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.6
6.4
21
49
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
18.6
6.3
9
5
Z3226
NOMESCO Finland
Physiotherapist
2.4
6.3
56
269
GDG10
NOMESCO Finland
Bilateral transplantation of lung
+∞
6.3
6
*
A31.9
ICD-10 Finland
Mycobacterial infection, unspecified
+∞
6.3
6
*
ZX121
NOMESCO Finland
Central venous catheter
+∞
6.3
6
*
2AA01
NOMESCO Finland
NA
+∞
6.3
6
*
J01GB01
ATC
tobramycin; inhalant, parenteral
+∞
6.3
6
*
2AX04
NOMESCO Finland
NA
+∞
6.3
6
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
6.3
6
*
NH4AE
NOMESCO Finland
Achilles tendon ultrasound examination
+∞
6.3
6
*
GDB10
NOMESCO Finland
Wedge resection of lung
27.5
6.3
8
*
A41.9
ICD-10 Finland
Sepsis, unspecified
4.9
6.3
19
41
J43.9
ICD-10 Finland
Emphysema, unspecified
8.9
6.1
12
14
Z2221
NOMESCO Finland
Medical doctor
2.2
6.1
77
431
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
5.8
6.1
16
29
ZX112
NOMESCO Finland
Subcutaneous
6.3
6.1
15
25
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.3
6.1
21
52
A03FA01
ATC
metoclopramide; systemic, rectal
2.4
6.0
56
273

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
86
17
73.52
154.67
3.9
1.3
u/ml
9.7
0.1
5.63
75
12
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
113
85
22.03
128.39
6.2
2.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
84
37
32.40
120.42
5.6
2.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
153
276
11.39
93.52
5.2
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
86
7
178.57
85.81
3.1
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
101
124
12.37
82.29
4.9
1.2
u/ml
1389.9
212.8
2.42
96
113
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
54
28
23.82
71.20
2.4
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
53
29
22.46
68.19
6.7
4.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
65
60
13.92
63.26
2.8
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
39
13
34.85
59.97
1.9
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
45
24
22.27
58.27
2.6
2.0
e9/l
1.0
0.8
0.58
15
13
(3005719) IgG [Mass/volume] in Serum or Plasma
97
177
7.96
55.40
4.8
2.3
g/l
9.4
10.7
2.10
86
162
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
58
62
11.62
50.79
4.6
1.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
51
46
13.41
49.91
20.3
7.7
iu/ml
261.1
114.7
—
17
8
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
56
63
10.93
47.17
4.5
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
48
43
13.34
47.09
4.6
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
45
37
14.37
46.47
5.0
3.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
52
54
11.67
46.30
2.3
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
44
44
11.74
39.99
2.4
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
119
361
5.08
37.75
4.6
1.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
176
727
5.03
37.58
20.3
6.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
114
338
5.08
37.11
3.5
1.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
35
28
14.20
36.48
5.5
2.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
116
357
4.92
35.88
12.3
3.4
mmol/l
0.8
0.8
1.52
110
334
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
42
46
10.62
35.72
2.3
1.6
—
—
—
0
0
(4062490)
33
25
14.88
35.45
1.4
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
39
39
11.51
35.32
1.5
2.0
g/l
0.6
1.0
0.57
25
34
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
35
30
13.24
34.97
5.5
1.9
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
31
22
15.77
34.48
2.7
2.2
e6/l
556.7
540.9
—
23
8
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
38
40
10.88
33.17
1.8
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
40
47
9.81
32.22
1.8
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
94
265
4.89
31.99
3.0
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
34
32
12.00
31.96
1.4
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
67
143
5.89
31.42
2.7
1.6
g/l
1.3
1.4
0.10
60
130
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
26
16
17.86
31.00
2.3
2.2
%
10.4
16.2
—
10
9
(3023368) Bacteria identified in Blood by Culture
150
648
3.93
27.74
10.8
4.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
24
16
16.35
27.41
2.0
2.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
21
11
20.60
26.82
7.3
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
21
11
20.60
26.82
7.3
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
21
11
20.60
26.82
7.3
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
21
11
20.60
26.82
7.3
2.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
86
256
4.45
26.82
3.2
1.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
203
1100
4.33
26.37
20.3
5.9
e9/l
0.7
0.6
4.22
193
959
(3006315) Basophils [#/volume] in Blood
203
1105
4.30
26.07
20.2
5.9
e9/l
0.0
0.0
1.94
195
967
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
20
10
21.51
26.02
6.8
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
20
10
21.51
26.02
6.8
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
20
10
21.51
26.02
6.7
2.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
84
257
4.28
25.09
3.4
2.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
20
11
19.55
24.96
1.7
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
203
1128
4.15
24.74
20.3
5.9
e9/l
1.7
1.8
0.76
195
1007
(3013115) Eosinophils [#/volume] in Blood
204
1139
4.16
24.65
22.8
6.2
e9/l
0.2
0.2
0.93
197
1014
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
25
22
12.41
24.35
1.4
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
27
28
10.60
23.61
2.9
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
30
36
9.24
23.59
3.0
1.5
—
—
—
0
0
(44790048)
29
34
9.43
23.20
3.2
1.7
—
—
—
0
0
(44790049)
29
34
9.43
23.20
3.2
1.7
—
—
—
0
0
(44806118)
29
34
9.43
23.20
3.2
1.7
—
—
—
0
0
(44790047)
29
34
9.43
23.20
3.2
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
25
24
11.37
23.01
3.0
2.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
50
108
5.45
22.78
1.7
2.5
g/l
1.9
1.5
1.37
39
96
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
18
10
19.20
22.28
5.3
6.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
20
14
15.34
22.14
2.1
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
59
153
4.65
21.62
3.0
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
70
6.34
21.54
4.2
2.4
u/ml
0.3
0.3
1.01
27
34
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
24
25
10.43
20.86
6.7
2.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
24
25
10.43
20.86
6.8
2.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
24
25
10.43
20.86
6.8
2.0
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
83
288
3.71
20.31
13.7
6.2
mmol/l
1.0
1.0
0.00
78
269
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
36
64
6.33
20.03
2.0
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
43
93
5.30
19.45
2.9
2.3
ug/l
0.9
3.8
0.50
43
86
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
176
993
3.19
18.74
10.8
5.9
mmol/l
1.2
1.2
0.25
171
900
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
24
8
32.71
18.68
3.2
1.5
—
—
—
0
0
(4015189)
23
7
35.69
18.28
7.9
3.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
19
17
11.94
18.18
1.9
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
86
328
3.37
17.92
1.8
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
117
543
3.03
17.35
24.3
7.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
182
1090
3.02
16.62
15.7
6.9
mmol/l
1.2
1.2
0.75
165
923
(3002179) Metamyelocytes/100 leukocytes in Blood
55
169
3.83
15.80
8.9
4.2
%
0.6
0.5
0.19
20
46
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
17
16
11.27
15.69
3.1
2.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
59
195
3.59
15.18
10.6
4.2
%
0.9
1.0
0.09
30
71
(3048929) Epstein Barr virus Ab [Presence] in Serum
31
64
5.34
14.66
1.5
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
25
43
6.30
14.27
1.8
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
25
43
6.30
14.27
1.8
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
69
261
3.20
14.26
6.3
6.6
mmol/l
1.9
0.9
1.06
57
206
(3024561) Albumin [Mass/volume] in Serum or Plasma
161
956
2.68
14.04
11.1
4.9
g/l
32.4
35.3
7.00
156
895
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
26
48
5.88
13.82
2.2
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
54
179
3.52
13.76
11.1
4.3
%
0.1
0.2
0.99
28
63
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
19
25
8.10
13.73
1.6
2.9
%
48.4
40.4
—
7
8
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
17
9.94
13.57
1.3
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
22
35
6.75
13.50
12.2
3.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
30
65
5.06
13.42
1.9
1.8
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
25
46
5.88
13.33
1.6
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
16
18
9.38
13.01
1.3
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
90
419
2.72
12.59
2.2
1.3
g/l
2.4
2.5
0.28
72
266
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
43
131
3.71
12.38
1.6
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
55
198
3.23
12.22
5.7
4.1
mmol/l
2.5
2.0
0.30
47
152
(3036489) Thrombin time
31
75
4.54
12.15
5.7
2.2
s
23.6
22.7
0.10
31
69
(3019060) Gas panel - Arterial blood
47
154
3.48
12.13
4.5
4.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
106
545
2.55
12.03
2.7
2.0
mg/l
3.4
3.1
0.58
91
470
(3006184) Hemoglobin [Mass/volume] in Capillary blood
25
52
5.19
11.68
1.6
2.5
g/l
118.2
127.1
0.65
12
36
(4010399)
49
171
3.28
11.42
2.2
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
28
66
4.61
11.31
2.0
1.2
—
—
—
0
0
(3012544) pH of Venous blood
55
207
3.08
11.29
5.7
4.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
15
6
26.32
11.26
2.5
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
67
284
2.80
11.09
1.6
1.4
titre
357.6
380.3
0.05
17
67
(3000991) Gas panel - Venous blood
49
174
3.22
11.09
6.2
7.7
—
—
—
0
0
(3024471) HLA-A [Type]
15
7
22.56
10.80
1.1
1.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
120
683
2.35
10.60
8.4
4.4
ph
7.4
7.4
0.47
19
127
(3032080) INR in Blood by Coagulation assay
152
957
2.33
10.60
12.6
9.3
inr
1.3
1.3
0.03
38
274
(3025159) Blasts/100 leukocytes in Blood
47
168
3.17
10.50
11.4
4.4
%
0.0
0.2
0.57
25
52
(3026250) Tacrolimus [Mass/volume] in Blood
15
8
19.75
10.38
28.4
31.5
ug/l
7.6
6.7
—
15
8
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
14
18
8.15
10.23
1.9
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
42
143
3.29
10.14
8.6
3.7
mmol/l
2.1
1.7
0.49
37
107
(3009343) pH of Capillary blood
44
156
3.17
9.94
9.2
3.5
ph
7.4
7.4
—
8
15
(3024932) HLA-DR beta [Type]
14
7
20.98
9.90
1.3
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
124
732
2.28
9.89
6.7
3.3
mmol/l
2.3
2.3
1.85
113
638
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
30
84
3.89
9.69
8.0
1.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
216
1620
2.62
9.66
11.4
4.1
mm/h
24.3
12.5
8.90
206
1483
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
122
725
2.24
9.48
8.1
3.8
u/l
30.9
32.8
0.25
122
684
(3045142) Bone marrow Pathology biopsy report
17
30
5.98
9.40
1.9
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
25
63
4.27
9.28
9.0
3.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
150
978
2.19
9.14
26.9
10.0
e9/l
0.0
0.0
0.05
133
805
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
72
347
2.46
9.03
5.7
3.1
e6/l
0.6
1.8
2.11
54
200
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
130
810
2.16
8.80
5.7
3.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
15
25
6.29
8.75
2.9
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
15
25
6.29
8.75
2.9
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
25
6.29
8.75
2.9
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
15
25
6.29
8.75
2.9
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
15
25
6.29
8.75
2.9
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
27
76
3.83
8.64
4.1
1.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
12
6
20.83
8.54
2.9
1.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
20
45
4.72
8.52
1.5
1.1
u/ml
347.4
312.9
—
10
24
(3030905) Polymorphonuclear cells [#/volume] in Blood
18
37
5.14
8.49
2.9
2.7
e9/l
5.6
4.9
0.34
18
37
(3005988) Vibrio sp identified in Specimen by Organism specific culture
15
26
6.05
8.42
2.9
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
36
125
3.17
8.39
2.5
1.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
104
605
2.16
8.28
5.8
3.2
e6/l
0.5
0.5
0.01
90
452
(3026782) Osmolality of Urine
83
443
2.26
8.16
3.7
2.9
mosm/kgh2o
561.7
566.6
0.07
74
374
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
220
1717
2.47
8.12
27.8
8.1
u/l
86.2
80.0
1.05
213
1607
(3042733) HLA Ab [Presence] in Serum
11
5
22.83
8.08
4.7
4.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
18
39
4.87
8.00
2.9
3.2
%
59.4
60.7
0.13
18
39
(3013826) Glucose [Moles/volume] in Serum or Plasma
183
1339
2.12
7.71
9.7
4.5
mmol/l
6.5
6.7
0.79
174
1252
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
129
838
2.03
7.47
3.1
2.3
nmol/l
78.9
76.8
0.33
120
737
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
87
489
2.15
7.44
3.4
1.7
mg/l
1.6
1.4
0.24
76
398
(3002582) Erythrocytes [#/volume] in Urine
110
679
2.04
7.30
6.0
3.3
e6/l
67.8
154.6
0.39
95
534
(3000492) Spirometry study
48
210
2.56
7.29
2.4
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
34
4.94
7.26
1.4
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
70
364
2.24
7.24
5.5
2.9
e6/l
0.7
0.9
0.54
52
212
(3048879) Bone marrow aspiration report
10
5
20.68
7.18
6.2
3.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
14
27
5.41
7.05
1.3
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
8
14.26
6.95
1.4
1.3
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
11
8
14.26
6.95
4.3
3.3
%
109.4
95.2
—
11
8
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
17
6.70
6.83
1.5
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
40
165
2.67
6.82
2.7
2.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
47
210
2.50
6.82
5.5
3.0
e9/l
60.8
70.1
0.96
37
159
(36304419) Bacteria [Presence] in Urine
98
592
2.02
6.82
5.7
3.1
—
—
—
0
0
(4035726)
45
198
2.53
6.74
1.8
1.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
51
238
2.41
6.74
6.9
6.8
%
95.0
95.5
0.35
51
229
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
101
3.09
6.71
2.3
1.4
g/l
4.1
3.9
0.17
21
75
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
101
3.09
6.71
2.3
1.4
g/l
8.1
7.5
0.69
21
80
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
101
3.09
6.71
2.3
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
12
21
5.93
6.64
1.0
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
132
890
1.94
6.64
4.2
2.6
ug/l
448.1
147.5
1.05
125
809
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
11
18
6.33
6.48
1.5
1.6
u/l
11.1
16.3
1.40
11
18
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
18
6.33
6.48
1.8
1.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
22
66
3.54
6.43
5.0
2.4
mmol/l
24.2
24.4
0.09
22
54
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
5
18.54
6.30
1.1
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
13
26
5.20
6.29
10.9
2.8
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
6
0
+∞
6.27
2.7
0.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
6
0
+∞
6.27
1.0
0.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
185
1413
1.97
6.24
6.9
4.3
e6/l
19.0
2239.7
—
5
33
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
88
527
1.99
6.18
8.2
2.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
67
363
2.12
6.17
3.6
2.5
umol/l
10.4
13.2
2.33
61
335
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
8
12.91
6.13
1.1
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
18
49
3.86
6.03
2.1
1.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
36
150
2.61
6.01
1.6
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
30
114
2.83
5.96
11.5
3.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
78
455
2.00
5.86
4.5
3.5
ng/l
378.9
197.2
0.60
65
360
(3044640) Blood type and Crossmatch panel - Blood
109
712
1.89
5.86
9.6
2.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
11
20
5.69
5.85
12.0
2.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
16
41
4.08
5.80
3.3
2.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
18
52
3.64
5.55
1.6
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
116
783
1.84
5.55
6.8
3.8
e6/l
12.0
73.7
3.35
98
572
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
95
2.92
5.54
2.5
1.5
g/l
3.5
3.2
0.65
21
77
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
60
324
2.09
5.53
3.5
2.5
%
18.2
23.3
1.25
50
286
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
30
119
2.71
5.51
9.7
7.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
79
472
1.95
5.50
3.8
2.6
e6/l
3.7
4.0
0.12
72
422
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
17
48
3.71
5.42
2.9
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
126
879
1.81
5.37
2.5
2.0
pmol/l
98.4
93.8
0.54
88
455
(3026493) Urate [Moles/volume] in Serum or Plasma
93
593
1.86
5.29
7.8
2.9
umol/l
337.2
7224.6
2.68
84
517
(3003327) Ova and parasites identified in Stool by Light microscopy
19
59
3.39
5.28
2.2
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
19
59
3.39
5.28
1.7
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
60
336
2.01
4.99
3.5
2.5
g/l
2.1
2.3
1.31
55
311
(3019225) pH of Specimen
43
212
2.22
4.97
11.3
4.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
14
37
3.93
4.88
2.4
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
10
9.26
4.82
2.2
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
10
9.26
4.82
2.2
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
10
9.26
4.82
2.2
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
10
9.26
4.82
2.2
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
70
420
1.90
4.74
1.8
1.7
nmol/l
983.0
1203.8
1.49
56
315
(3028626) Oxygen [Partial pressure] in Capillary blood
17
53
3.35
4.70
5.4
2.6
kpa
7.5
8.0
0.73
17
45
(3002173) Hemoglobin [Mass/volume] in Arterial blood
43
218
2.16
4.63
7.7
7.1
g/l
121.0
121.6
0.07
43
212
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
11
8.42
4.59
2.0
1.5
u/ml
2737.4
1064.2
—
9
11
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
9
11
8.42
4.59
2.9
1.3
ug/l
37.0
68.5
—
9
11
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
8
10.26
4.55
1.1
1.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
85
549
1.80
4.54
2.0
1.6
nmol/l
18.4
20.6
0.93
80
462
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
40
199
2.18
4.51
2.6
2.6
u/l
28.3
34.0
0.69
35
167
(4306422)
12
30
4.14
4.48
1.2
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
21
77
2.87
4.46
2.1
3.3
mg/l
36.7
40.0
0.13
16
63
(3042111) Morphology [Interpretation] in Bone marrow Narrative
17
55
3.23
4.44
4.3
1.9
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
12
7.71
4.39
1.7
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
6
11.93
4.30
1.1
1.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
6
11.93
4.30
2.0
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
13
36
3.74
4.26
1.9
3.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
13
7.12
4.19
1.7
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
23
4.48
4.12
1.3
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
8
10
8.20
4.09
1.3
1.1
mmol/l
2.0
1.8
—
8
10
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
125
920
1.66
4.08
4.6
3.8
ng/l
32.7
44.6
0.66
97
666
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
96
659
1.71
4.08
3.3
2.1
u/l
171.0
228.3
0.37
91
626
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
20
76
2.76
3.99
2.1
3.1
—
1.3
—
0
11
(3037467) Urinalysis macro (dipstick) panel - Urine
183
1493
1.69
3.95
7.0
4.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
116
844
1.65
3.92
2.7
2.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
16
54
3.09
3.92
2.2
3.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
76
494
1.75
3.90
13.1
5.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
14
44
3.30
3.83
5.4
2.8
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
19
72
2.76
3.82
1.6
1.5
iu/ml
2.0
0.1
—
5
18
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
12
34
3.65
3.81
1.2
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
12
34
3.65
3.81
1.5
1.2
u/ml
1.3
1.3
—
6
10
(3017143) Hepatitis C virus Ab [Presence] in Serum
44
243
1.97
3.77
2.0
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
48
274
1.91
3.74
1.9
1.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
12
6.83
3.70
2.0
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
133
1013
1.61
3.67
10.7
4.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
18
68
2.76
3.64
8.6
6.3
mmol/l
1.2
1.3
0.20
18
60
(3008152) Bicarbonate [Moles/volume] in Arterial blood
31
153
2.16
3.57
8.1
6.7
mmol/l
25.0
24.1
0.77
31
144
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
43
240
1.94
3.57
5.1
3.3
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
19
75
2.65
3.55
1.4
1.3
—
3.0
—
0
6
(3016018) Differential panel - Cerebral spinal fluid
8
13
6.30
3.52
2.5
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
6
10.19
3.51
2.0
1.3
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
6
6
10.19
3.51
2.3
2.7
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
7
10
7.15
3.38
13.1
4.5
%
40.6
50.1
—
7
10
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
10
7.15
3.38
1.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
12
38
3.26
3.25
1.5
1.2
u/ml
1.4
4.0
—
5
16
(3025941) Bacteria identified in Stool by Culture
25
118
2.23
3.22
1.9
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
16
5.12
3.07
1.9
2.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
16
5.12
3.07
1.9
2.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
12
5.95
3.04
1.6
2.6
%
8.5
11.2
—
7
12
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
21
4.39
3.02
1.3
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
198
2211
0.62
3.00
4.8
5.1
mmol/l
2.6
2.7
0.57
184
2011
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
192
2159
0.62
3.00
4.6
4.5
mmol/l
1.4
1.4
0.25
180
1967
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
17
4.81
2.94
1.5
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
87
626
1.57
2.92
3.4
2.9
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
9
6.79
2.88
1.3
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
36
3.14
2.84
1.3
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
23
4.01
2.80
1.3
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
6
8.46
2.76
1.2
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
6
8.46
2.76
1.2
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
19
4.30
2.70
1.0
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
20
93
2.24
2.68
9.0
5.1
%
1.8
1.6
0.50
20
86
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
25
3.69
2.60
1.2
1.1
u/ml
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
195
2168
0.64
2.59
4.6
4.6
mmol/l
4.5
4.5
0.22
183
1984
(3019832) Treponema pallidum Ab [Presence] in Serum
24
125
2.01
2.44
2.0
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
148
1226
1.45
2.40
3.4
2.7
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
8
6.34
2.38
2.0
2.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
8
6.34
2.38
1.2
1.1
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
13
53
2.53
2.31
7.3
5.6
mmol/l
103.9
105.5
0.95
13
48
(3039000) Anion gap in Blood
13
53
2.53
2.31
7.3
5.6
mmol/l
11.9
11.2
0.40
13
48
(3007930) Methemoglobin/Hemoglobin.total in Blood
19
93
2.12
2.27
9.5
5.2
%
0.9
0.9
0.30
19
87
(3017732) Neutrophils [#/volume] in Blood
27
152
1.86
2.21
4.0
2.5
e9/l
6.1
4.1
0.94
17
118
(3044889) 12 lead EKG panel
179
1551
1.45
2.20
6.5
4.0
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
8
24
3.40
2.19
1.5
1.5
e6/l
2176.0
1480.9
—
8
16
(3034426) Prothrombin time (PT)
5
10
5.07
2.08
1.2
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
20
3.56
2.07
1.6
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
20
3.56
2.07
14.1
3.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
44
2.56
2.04
1.4
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
26
3.14
2.03
2.3
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
26
3.14
2.03
2.3
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
16
78
2.12
1.95
1.8
1.8
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
11
4.61
1.95
2.4
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
52
2.37
1.90
1.2
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
22
3.24
1.89
1.4
3.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
21
115
1.90
1.89
2.6
2.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
23
3.10
1.81
2.9
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
7
23
3.10
1.81
1.6
1.5
e6/l
9657.1
32223.5
—
7
13
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
29
2.81
1.80
4.6
2.2
pg
30.8
33.0
—
8
29
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
47
2.40
1.80
1.1
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
24
140
1.78
1.79
2.2
2.4
—
15.3
—
0
7
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
18
3.38
1.75
8.2
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
234
2172
1.55
1.75
59.1
15.1
mg/l
30.7
25.0
1.83
219
1725
(3012441) Differential panel - Pleural fluid
7
24
2.97
1.73
1.6
1.7
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
11
48
2.35
1.73
1.1
1.2
—
56.4
—
0
5
(3014051) Protein [Presence] in Urine by Test strip
10
42
2.43
1.69
1.9
2.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
63
472
1.44
1.67
3.5
3.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
25
2.85
1.66
1.9
1.2
—
—
—
0
0
(3013512) EKG study
87
693
1.38
1.62
6.2
4.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
70
2.05
1.62
1.9
2.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
32
2.54
1.61
1.0
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
20
3.04
1.59
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
211
1931
1.41
1.58
48.5
16.0
%
37.3
39.9
3.53
150
1362
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
164
1444
1.34
1.57
7.7
3.3
u/l
70.4
50.1
1.24
158
1350
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
192
2088
0.73
1.56
4.5
4.1
mmol/l
1.3
1.3
0.33
181
1899
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
15
3.37
1.53
1.6
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
27
2.63
1.52
1.0
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
27
2.63
1.52
1.0
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
21
2.90
1.51
1.0
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
12
59
2.08
1.46
1.5
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
12
59
2.08
1.46
1.5
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
16
3.16
1.44
2.2
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
16
3.16
1.44
1.0
1.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
22
2.76
1.44
1.0
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
125
1068
1.32
1.43
5.8
4.8
estimate
0.0
0.0
0.00
25
188
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
60
2.05
1.40
1.5
1.2
—
—
—
0
0
(4268621)
7
29
2.45
1.40
2.3
2.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
33
226
1.52
1.37
1.9
2.6
ug/g
381.5
130.2
0.75
25
179
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
17
2.98
1.36
2.2
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
62
484
1.36
1.29
1.7
1.8
pmol/l
500.4
448.6
0.51
55
403
(3035350) Ketones [Presence] in Urine by Test strip
124
1071
1.29
1.27
4.2
3.6
estimate
0.0
0.0
0.00
23
194
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
6
25
2.43
1.25
1.2
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
125
1083
1.29
1.24
4.3
3.6
estimate
0.0
0.0
0.00
24
183
(40768797) Stomach Pathology biopsy report
42
311
1.41
1.20
1.6
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
11
57
1.97
1.18
1.3
1.3
—
3.2
—
0
10
(1761868) Lipid panel - Serum or Plasma
64
788
0.75
1.17
3.2
2.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
24
159
1.56
1.16
4.1
2.8
ml/min/173m2
52.6
64.2
0.72
12
73
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
191
2046
0.78
1.08
5.5
6.1
mmol/mol
40.6
40.3
0.17
178
1893
(3003694) ABO and Rh group [Type] in Blood
69
562
1.31
1.08
1.8
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
22
2.30
1.04
1.0
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
7
34
2.09
1.03
2.4
9.2
mmol/l
6.5
7.0
—
7
28
(3021788) Differential panel - Synovial fluid
7
35
2.03
1.00
1.0
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
201
2132
0.78
0.98
5.3
4.7
mmol/l
6.0
6.0
0.25
193
1937
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
62
1.81
0.95
1.1
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
17
110
1.58
0.93
2.8
2.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
30
2.02
0.87
1.5
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
191
1788
1.23
0.81
59.7
18.9
%
14.6
13.7
4.49
191
1755
(4146454)
0
24
0.00
0.79
0.0
2.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
26
0.00
0.79
0.0
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
24
2.10
0.75
1.4
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
25
2.02
0.73
2.4
3.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
25
2.02
0.73
2.0
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
36
286
1.30
0.70
1.3
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
69
1.62
0.69
1.6
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
42
1.68
0.69
1.1
2.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
16
111
1.47
0.67
4.9
4.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
24
182
1.35
0.64
4.5
3.7
mmol/l
1.3
1.2
0.93
24
161
(3037121) Protein [Mass/volume] in Urine
12
79
1.54
0.63
2.3
3.5
g/l
0.3
0.2
—
6
27
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
175
0.67
0.63
1.6
1.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
167
1565
1.17
0.61
3.7
3.6
pmol/l
14.9
14.9
0.13
153
1386
(36660697) Celiac disease serology panel - Serum
20
151
1.35
0.55
1.2
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
14
99
1.44
0.55
1.5
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
41
343
1.23
0.54
1.4
1.3
iu/ml
17.4
38.7
2.01
12
123
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
76
846
0.86
0.50
3.7
4.4
%
21.1
21.4
0.08
38
410
(3022621) pH of Urine by Test strip
18
139
1.32
0.45
2.6
2.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
23
185
1.27
0.43
4.5
3.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
213
2060
1.16
0.42
40.2
14.0
ml/min/173m2
80.2
79.5
0.18
200
1696
(3022806) Fractional oxyhemoglobin in Capillary blood
5
33
1.52
0.41
1.8
1.5
%
86.6
90.0
—
5
33
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
33
1.52
0.41
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.0
—
251.2
—
0
11
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
17
0.00
0.41
0.0
1.0
—
36.1
—
0
10
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.0
—
549.9
—
0
11
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
34
1.48
0.40
4.8
3.4
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
34
1.48
0.40
4.8
3.4
mmol/l
4.1
4.1
—
5
34
(3035285) Chloride [Moles/volume] in Venous blood
5
34
1.48
0.40
4.8
3.4
mmol/l
110.2
105.4
—
5
34
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
3.9
—
25.0
—
0
6
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
42
1.44
0.36
1.0
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
30
256
1.19
0.35
1.2
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
12
154
0.77
0.33
2.0
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
22
184
1.21
0.31
3.5
3.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
29
252
1.17
0.28
4.6
4.4
ug/l
3.8
53.4
0.94
24
210
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
37
332
1.13
0.25
1.3
1.3
u/ml
4.2
13.2
1.01
13
135
(3019150) Specific gravity of Urine by Refractometry
52
477
1.11
0.24
4.2
3.8
kg/l
1.0
1.0
—
8
69
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
6
83
0.72
0.24
1.0
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
14
168
0.82
0.23
2.0
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
39
1.29
0.23
2.6
1.7
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
34
307
1.12
0.21
1.3
1.5
—
—
—
0
0
(3020891) Body temperature
11
89
1.25
0.21
4.4
4.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
43
1.17
0.21
1.2
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
12.6
—
841.6
—
0
13
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
16.4
—
1600.9
—
0
13
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
9.4
—
0.7
—
0
13
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
115
0.78
0.20
1.4
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
66
620
1.09
0.20
4.3
3.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
16
185
0.86
0.19
1.3
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
25
278
0.89
0.18
11.0
7.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
75
712
1.07
0.17
4.3
3.1
mmol/l
6.9
8.0
1.54
67
588
(3029937) Albumin [Presence] in Urine by Test strip
62
585
1.08
0.17
4.2
3.8
estimate
0.0
0.0
0.00
24
185
(3020682) Albumin/Creatinine [Ratio] in Urine
75
713
1.07
0.17
5.1
4.0
mg/mmol
19.9
7.6
1.15
55
465
(40761511) CBC panel - Blood by Automated count
230
2268
1.09
0.17
40.1
14.2
—
—
—
0
0
(4034850)
6
76
0.78
0.16
15.3
12.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
77
0.77
0.16
2.5
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
48
452
1.08
0.14
1.2
1.2
u/ml
1.0
1.4
0.36
16
127
(3012516) Albumin [Mass/volume] in Urine
71
681
1.06
0.12
4.1
3.2
mg/l
821.1
331.8
0.28
49
457
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
54
565
0.94
0.11
1.9
1.7
mmol/l
1.4
1.4
0.02
46
461
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
88
853
1.05
0.10
4.2
3.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
45
1.11
0.10
2.0
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
56
1.07
0.08
1.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
61
0.82
0.08
2.0
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
61
0.82
0.08
2.2
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
60
0.83
0.08
2.0
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
62
0.80
0.08
2.0
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
64
0.78
0.08
1.2
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
70
0.85
0.07
1.7
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
88
1.02
0.07
1.1
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
22
207
1.07
0.06
1.4
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
60
608
0.98
0.01
3.2
3.0
ug/l
0.6
0.8
1.46
47
402
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
21
217
0.97
0.01
2.1
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
11
116
0.95
0.00
1.0
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
196
1958
1.00
0.00
4.5
4.4
mu/l
1.8
2.0
1.04
181
1755
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
15
153
0.98
0.00
1.2
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
104
1043
1.00
0.00
5.0
5.0
ug/l
2.0
2.6
1.00
92
937
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
6
0.00
0.00
0.0
7.7
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
70
1.00
0.00
8.0
4.8
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
1.2
—
1.3
—
0
6
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
53.6
—
0
5
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
20.2
—
0
5
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
1.6
—
3698.2
—
0
5
(3002619) Bacteria identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
1.2
—
1.2
—
0
6
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
5.0
—
25.3
—
0
5
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
6
0.00
0.00
0.0
7.5
—
7.0
—
0
6
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
63
0.95
0.00
1.7
1.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
7.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
53
0.94
0.00
1.0
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(4133840)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
4.8
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
67
0.89
0.00
1.2
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_ASPERGILLOSIS and mortality.

Females

Parameter HR [95% CI] p-value
AB1_ASPERGILLOSIS 4.089 [3.03, 5.52] < 0.001
Birth year 0.994 [0.99, 1.0] 0.199

During the follow-up period (1.1.1998 — 31.12.2019), 157 out of 432 females with AB1_ASPERGILLOSIS died.

Males

Parameter HR [95% CI] p-value
AB1_ASPERGILLOSIS 5.317 [4.05, 6.99] < 0.001
Birth year 0.988 [0.98, 1.0] 0.016

During the follow-up period (1.1.1998 — 31.12.2019), 377 out of 732 males with AB1_ASPERGILLOSIS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_ASPERGILLOSIS.

N-year risk Females Males
1 0.413% 0.945%
5 2.448% 6.264%
10 6.095% 14.861%
15 11.683% 27.194%
20 19.595% 41.719%

Relationships between endpoints

↥

Index endpoint: AB1_ASPERGILLOSIS – Aspergillosis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data